Back
December 31, 2015
December 31, 2015
Episodes
All
All
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Iberdomide Plus Daratumumab/Dexamethasone for R/R Myeloma
2
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma
3
Frequently Asked Questions on the Evolving Management of Early-Stage HER2+ Breast Cancer
4
Study Finds Traditional Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit
5